Product Information
EVISTA 60 MG TABLET is a brand product labeled by Eli Lilly and Company, priced at $6.3237 per EA under NDC 00002418430. Its NADAC has been published 310 times since Jul 26, 2017.
The High Outlier badge above means this manufacturer's average price in the Raloxifene hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
60 mg/1
Manufacturer
Eli Lilly and CompanyNDC
00002418430
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
RALOXIFENE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA020815On Market Since
1/6/1998
Pharmacological Classes
Price Statistics
The NADAC for EVISTA 60 MG TABLET has been published 310 times since Jul 26, 2017, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.3237 per EA |
|---|---|
| All-time high | $6.3737 (Jun 12, 2019) |
| All-time low | $6.3153 (Jul 26, 2017) |
| 52-week high | $6.3408 |
| 52-week low | $6.3199 |
| Median price | $6.3296 |
| Average price | $6.3400 |
| Largest weekly change | +0.9% (Sep 20, 2017) |
| Weeks tracked | 310 |
| Tracking since | Jul 26, 2017 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EVISTA 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EVISTA 60 MG TABLET, manufactured by Eli Lilly and Company, is $6.3237 per EA (NDC 00002418430), effective Jun 24, 2026.
How has the price of EVISTA 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for EVISTA 60 MG TABLET has held within roughly two percent of its current level. It has been tracked across 310 weekly CMS publications since Jul 26, 2017.
What are the highest and lowest recorded NADAC prices for EVISTA 60 MG TABLET?
Since Jul 26, 2017, the NADAC for EVISTA 60 MG TABLET has ranged from a low of $6.3153 (Jul 26, 2017) to a high of $6.3737 (Jun 12, 2019), with a median of $6.3296 per EA.
Are there cheaper alternatives to EVISTA 60 MG TABLET?
Yes. 3 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, RALOXIFENE HCL 60 MG TABLET, is $0.2399 per EA — about 96% below EVISTA 60 MG TABLET.
Who manufactures EVISTA 60 MG TABLET?
EVISTA 60 MG TABLET (NDC 00002418430) is labeled by Eli Lilly and Company, and CMS classifies it as a brand product.
Related Drugs
Same classification